Return
Company Page
Relay Therapeutics
Founders
Relay Therapeutics is a clinical-stage precision medicine company transforming drug discovery through its proprietary Dynamo platform, which analyzes protein motion to identify novel drug targets. The company combines computational biology, structural biology, and biophysics to develop breakthrough therapies for cancer and genetic diseases, focusing on previously intractable or inadequately addressed protein targets.
Company Founded in 2016
